The company's drug-eluting stent technologies have been developed through a technological collaboration with the prestigious ...

Utah's life sciences sector is a significant economic powerhouse, but the misguided the Medication Affordability and Patent ...

Undergoing percutaneous coronary intervention (PCI) for narrowed arteries with a novel bioadaptor is at least as effective as ...

The DynamX Bioadaptor device was noninferior to DES for TLF overall, but a landmark analysis reveals a potential strength.

The trial was set up to give DCBs their “best shot” in this patient group, says one researcher, but it’s tough to beat current DES.

Most of the overdue plants are in the US, but more than 340 are in India and China, countries that together make up the largest source of drug ingredients ... Rogers offered no date for when ...

Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent ... with longer follow-up. Using intravascular imaging to guide stent implantation during ...

Drug addiction is a treatable, chronic medical disease that involves complex interactions between a person’s environment, brain circuits, genetics, and life experiences. People with drug addictions ...

The drug, nicknamed the ‘Frankenstein’ of opioids, can be up to 500 times more potent than Heroin and 50 times stronger than fentanyl. “It’s been a living hell, you lose your son,” his ...

Now, all eyes will be on the reviewers’ briefing document that will be published in the build-up to the meeting to get an idea of the FDA’s stance on the drug. Lilly had previously sought ...

1, while others will take months to get their programs up and running. A majority of those counties will only allow people charged with misdemeanor drug possession to enter their deflection program.